Ignite Creation Date:
2024-05-19 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06419374
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2024-05-14
Brief Title:
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants with Compensated Cirrhosis Due to MASH
Sponsor:
89bio Inc
Organization:
89bio Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Metabolic Dysfunction-Associated Steatohepatitis MASH Nonalcoholic Steatohepatitis NASH With Compensated Cirrhosis |
Keywords:
| Name | View |
|---|---|
| Liver disease | View |
| Fatty Liver | View |
| Digestive System Diseases | View |
| Metabolic diseases | View |
| Metabolic Dysfunction-Associated Steatohepatitis | View |
| MASH | View |
| Nonalcoholic steatohepatitis | View |
| NASH | View |
| Metabolic dysfunction-associated steatotic liver disease | View |
| MASLD | View |
| Nonalcoholic fatty liver disease | View |
| NAFLD | View |
| Fibrosis | View |
| Cirrhosis | View |